Zydus Lifesciences Q2 Results: Net profit jumps 14% YoY to Rs 911 crore
Zydus Lifesciences reported a net profit jump of 14% to Rs 911 crore in Q2FY25 led by robust sales growth in India and US markets.
The drug maker had reported a net profit of Rs 801 crore in the July-September quarter of last fiscal.
Revenue from operations grew 20% YoY to Rs 5237 crore.
On a quarter-on-quarter (QoQ) basis the net profit declined 35.8% and revenue by 15.6%.
The earnings before interest, tax, depreciation and ammortisation (EBITDA) increased 27.5% YoY to Rs 1461.4 crore. On QoQ, EBITDA dropped 29.9%.
Stock Trading
Point & Figure Chart Mastery: A Comprehensive Trading Guide
By — Mukta Dhamankar, Full Time Trader, 15 Years Experience, Instructor
Stock Trading
Cryptocurrency Made Easy: Cryptocurrency Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Technical Analysis Made Easy: Online Certification Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Stock Markets Made Easy
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Mastering Options Selling: Advanced Strategies for Success
By — CA Manish Singh, Chartered Accountant, Professional Equity and Derivative Trader
Stock Trading
Commodity Markets Made Easy: Commodity Trading Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Algo Trading Made Easy
By — Vivek Gadodia, Partner at Dravyaniti Consulting and RBT Algo Systems
Stock Trading
Advanced Strategies in Stock Market Mastery
By — CA Raj K Agrawal, Chartered Accountant
Stock Trading
Technical Analysis Demystified: A Complete
